These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
496 related items for PubMed ID: 16105567
1. In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004). Hoban DJ, Bouchillon SK, Johnson BM, Johnson JL, Dowzicky MJ, Tigecycline Evaluation and Surveillance Trial (TEST Program) Group. Diagn Microbiol Infect Dis; 2005 Jul; 52(3):215-27. PubMed ID: 16105567 [Abstract] [Full Text] [Related]
5. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia. Fritsche TR, Sader HS, Stilwell MG, Dowzicky MJ, Jones RN. Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563 [Abstract] [Full Text] [Related]
6. Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents. Sader HS, Jones RN, Stilwell MG, Dowzicky MJ, Fritsche TR. Diagn Microbiol Infect Dis; 2005 Jul; 52(3):181-6. PubMed ID: 16105562 [Abstract] [Full Text] [Related]
7. Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study. Betriu C, Rodríguez-Avial I, Gómez M, Culebras E, López F, Alvarez J, Picazo JJ, Spanish Tigecycline Group. Diagn Microbiol Infect Dis; 2006 Dec; 56(4):437-44. PubMed ID: 16949245 [Abstract] [Full Text] [Related]
8. In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: tigecycline Evaluation and Surveillance Trial 2004 to 2007. Garrison MW, Mutters R, Dowzicky MJ. Diagn Microbiol Infect Dis; 2009 Nov; 65(3):288-99. PubMed ID: 19733459 [Abstract] [Full Text] [Related]
18. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003). Sader HS, Fritsche TR, Jones RN. Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569 [Abstract] [Full Text] [Related]
19. Multicenter study to assess the in vitro activity of tigecycline by disk diffusion test against clinical isolates from Argentina. Fernández Canigia L, Kaufman S, Lanata L, Vay C, Giovanakis M, Bantar C, Argentinean Tigecycline Surveillance Group. Chemotherapy; 2009 Jul; 55(1):20-7. PubMed ID: 18974645 [Abstract] [Full Text] [Related]
20. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011. Kanj SS, Whitelaw A, Dowzicky MJ. Int J Antimicrob Agents; 2014 Feb; 43(2):170-8. PubMed ID: 24315313 [Abstract] [Full Text] [Related] Page: [Next] [New Search]